Credit Suisse’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-88,987
| Closed | -$30K | – | 3913 |
|
|
2016
Q3 | $30K | Sell |
88,987
-48,689
| -35% | -$16.4K | ﹤0.01% | 3703 |
|
|
2016
Q2 | $64K | Buy |
137,676
+124,163
| +919% | +$57.7K | ﹤0.01% | 3817 |
|
|
2016
Q1 | $18K | Sell |
13,513
-46,210
| -77% | -$61.6K | ﹤0.01% | 3631 |
|
|
2015
Q4 | $88K | Buy |
59,723
+14,515
| +32% | +$21.4K | ﹤0.01% | 3853 |
|
|
2015
Q3 | $71K | Sell |
45,208
-4,510
| -9% | -$7.08K | ﹤0.01% | 3924 |
|
|
2015
Q2 | $85K | Sell |
49,718
-12,437
| -20% | -$21.3K | ﹤0.01% | 4110 |
|
|
2015
Q1 | $86K | Sell |
62,155
-141,558
| -69% | -$196K | ﹤0.01% | 3958 |
|
|
2014
Q4 | $307K | Buy |
203,713
+130,091
| +177% | +$196K | ﹤0.01% | 3675 |
|
|
2014
Q3 | $151K | Buy |
73,622
+11,886
| +19% | +$24.4K | ﹤0.01% | 3827 |
|
|
2014
Q2 | $189K | Sell |
61,736
-358,091
| -85% | -$1.1M | ﹤0.01% | 3965 |
|
|
2014
Q1 | $1.05M | Buy |
419,827
+344,186
| +455% | +$861K | ﹤0.01% | 2745 |
|
|
2013
Q4 | $375K | Sell |
75,641
-36,109
| -32% | -$179K | ﹤0.01% | 3500 |
|
|
2013
Q3 | $255K | Buy |
111,750
+69,316
| +163% | +$158K | ﹤0.01% | 3437 |
|
|
2013
Q2 | $94K | Buy |
+42,434
| New | +$94K | ﹤0.01% | 3628 |
|